Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans
- 1 June 1976
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 4 (3), 199-230
- https://doi.org/10.1007/bf01063614
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Protein Binding and Erythrocyte Partitioning of Disopyramide and Its Monodealkylated MetaboliteJournal of Pharmaceutical Sciences, 1974
- Pharmacokinetics of Trichloroethanol and Metabolites and Interconversions Among Variously Referenced Pharmacokinetic ParametersJournal of Pharmaceutical Sciences, 1973
- Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosingJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Electrophysiologic effects of disopyramide phosphate—A new antiarhythmic agentThe American Journal of Cardiology, 1973
- Species Differences in the Biotransformation of a New Antiarrhythmic Agent: Disopyramide PhosphateJournal of Pharmaceutical Sciences, 1972
- Effect of Parallel First-Order Drug Loss from Site of Administration on Calculated Values for Absorption Rate ConstantsJournal of Pharmaceutical Sciences, 1972
- Integral Coefficients of Multi-Compartment Pharmacokinetic ModelsChemotherapy, 1972
- Effects of Protein Binding of Drugs on Areas under Plasma Concentration—Time CurvesJournal of Pharmaceutical Sciences, 1972
- Pharmacokinetic Basis for the Influence of Route of Administration on the Area Under the Plasma Concentration-Time CurveJournal of Pharmaceutical Sciences, 1969
- CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE “EVANS BLUE” AND THE SPECTROPHOTOMETERJournal of Clinical Investigation, 1937